Company announcements, industry insights, and thought leadership on clinical trial innovation.
Validcare and Univo IRB unite eSource and a modern IRB to give sponsors, sites, and regulators real-time visibility into clean trial data—start to finish.
Validcare is the Performance-Based CRO. The Real-Time Clinical Trials initiative FDA announced in April 2026 is the architecture Validcare delivers today on the SmartSource™ Clinical Trial Platform — and has been delivering since 2014.
Validcare selected as CRO for Phase 2a clinical study examining DMT treatment in stroke patients, with equity investment aligning incentives toward timely completion and data quality.
Insights from the JPMorgan Healthcare Conference 2025 on the critical communication gap between emerging biotech companies and investors.
Validcare partners with Coologics to conduct a multi-center study evaluating the Vlisse vaginal cooling device for vulvovaginal candidiasis, supporting FDA market approval.
Success in decentralized clinical trials depends not on technology, but on people, leadership, change management, and understanding human nature.
Validcare partners with TECLens to support clinical development of qCXL technology for presbyopia treatment, providing protocol development, data collection, and statistical analysis.
Validcare contracted to manage a 440-infant Growth Monitoring Study across 13 U.S. sites to support FDA market authorization for Bubs infant formula products.
Real-World Research Ltd joins Validcare platform, combining RWE expertise with operational infrastructure to deliver world-class real-world evidence studies.
Strategic partnership announced to enhance clinical trial execution, combining Validcare's platform with Farmacon's expertise in Latin American emerging markets.
Integration partnership combines patient-centric automation with clinical operations expertise, giving pharma sponsors visibility, tools, and control over trial success.
FIU selects Validcare's platform for hybrid and decentralized clinical trials, enabling broader geographic participant access and improved diversity.
Garden of Life partners with Validcare for the largest clinical trial ever performed for women studying its probiotic supplement, leveraging decentralized trial technology.
Investigators report to FDA no evidence of liver toxicity in the 839 adults consuming oral CBD in industry-sponsored decentralized human safety study.
No articles found in this category.
Contact us to learn how Validcare can deliver an exceptional CRO experience.
Loading form…
